| 251 |
16123337 | Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. | 2005 Sep |
1 |
| 252 |
16123353 | ATP and sulfonylurea sensitivity of mutant ATP-sensitive K+ channels in neonatal diabetes: implications for pharmacogenomic therapy. | 2005 Sep |
1 |
| 253 |
16200937 | [Triple oral therapy in type 2 diabetes]. | 2005 Aug 24 |
1 |
| 254 |
16285076 | Insulin in type 2 diabetes: a useful alternative despite limited assessment based on surrogate endpoints. | 2005 Oct |
1 |
| 255 |
16313276 | Pharmacological interventions that directly stimulate or modulate insulin secretion from pancreatic beta-cell: implications for the treatment of type 2 diabetes. | 2005 Dec |
1 |
| 256 |
20496449 | | 2005 May |
1 |
| 257 |
14737744 | All-cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanides. | 2004 Jan-Feb |
1 |
| 258 |
14760321 | Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes. | 2004 Feb |
2 |
| 259 |
15125825 | Starting insulin in type 2 diabetes: continue oral hypoglycemic agents? A randomized trial in primary care. | 2004 May |
1 |
| 260 |
15139733 | 'I don't feel like a diabetic any more': the impact of stopping insulin in patients with maturity onset diabetes of the young following genetic testing. | 2004 Mar-Apr |
1 |
| 261 |
15140339 | Pioglitazone as monotherapy or in combination with sulfonylurea or metformin enhances insulin sensitivity (HOMA-S or QUICKI) in patients with type 2 diabetes. | 2004 May |
4 |
| 262 |
15307693 | [Clinical observation on effect of Yiqi Yangyin Huoxue Tongfu principle in treating diabetes mellitus type 2 of secondary failure to sulfonylurea agents]. | 2004 Jul |
1 |
| 263 |
15356061 | Beta-cell insulin secretory response to oral hypoglycemic agents is blunted in humans in vivo during moderate hypoglycemia. | 2004 Sep |
1 |
| 264 |
15448106 | Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. | 2004 Oct |
1 |
| 265 |
15469778 | Optimizing combination therapy for type 2 diabetes in adolescents and adults: a case-based approach. | 2004 Oct |
1 |
| 266 |
15531505 | Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. | 2004 Nov |
1 |
| 267 |
15561904 | The impact of ATP-sensitive K+ channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium. | 2004 Dec |
1 |
| 268 |
12437993 | Adenosine triphosphate-binding cassette transporter genes in ageing and age-related diseases. | 2003 Jan |
1 |
| 269 |
12606519 | The insulin secretory granule is the major site of K(ATP) channels of the endocrine pancreas. | 2003 Mar |
1 |
| 270 |
12766121 | Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes. | 2003 Jun |
1 |
| 271 |
14565810 | Efficacy of sulfonylureas with insulin in type 2 diabetes mellitus. | 2003 Nov |
4 |
| 272 |
14575972 | Genetic cause of hyperglycaemia and response to treatment in diabetes. | 2003 Oct 18 |
1 |
| 273 |
14606302 | [Oral antidiabetic drugs in 2003]. | 2003 Sep |
1 |
| 274 |
17682309 | Fasting insulin levels as a measure of insulin resistance in American blacks. | 2003 |
1 |
| 275 |
11815455 | Sulfonylurea-mediated stimulation of insulin exocytosis via an ATP-sensitive K+ channel-independent action. | 2002 Feb |
2 |
| 276 |
11815505 | Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). | 2002 Feb |
5 |
| 277 |
11879723 | Insulin responses to sulfonylureas. | 2002 Apr |
1 |
| 278 |
12015189 | Participation of high glucose concentrations in neutrophil adhesion and surface expression of adhesion molecules on cultured human endothelial cells: effect of antidiabetic medicines. | 2002 May-Jun |
1 |
| 279 |
12021091 | Insulin intervention to preserve beta cells in slowly progressive insulin-dependent (type 1) diabetes mellitus. | 2002 Apr |
1 |
| 280 |
12067822 | Insulin improves fasting and postprandial lipemia in type 2 diabetes. | 2002 Jun |
1 |
| 281 |
12118200 | Sulfonylurea receptor gene 16-3 polymorphism - association with sulfonylurea or insulin treatment in type 2 diabetic subjects. | 2002 Jul |
1 |
| 282 |
12387036 | [Combination therapy of insulin sensitizer, thiazolidinedione drugs, and sulfonylurea]. | 2002 Sep |
1 |
| 283 |
12409500 | Gliclazide increases insulin receptor tyrosine phosphorylation but not p38 phosphorylation in insulin-resistant skeletal muscle cells. | 2002 Dec |
3 |
| 284 |
12489381 | Treating dual defects in diabetes: insulin resistance and insulin secretion. | 2002 Dec 1 |
1 |
| 285 |
12520825 | Current therapeutic strategies for type 2 diabetes mellitus. | 2002 Nov |
1 |
| 286 |
12568204 | Immunoreactive insulin response to a single dose of glimepiride in lean type 2 diabetic subjects. | 2002 Oct |
1 |
| 287 |
11232737 | Management of type 2 diabetes mellitus in the elderly: special considerations. | 2001 |
1 |
| 288 |
11318844 | Correction of hyperglycaemia reduces insulin resistance and serum soluble E-selectin levels in patients with Type 2 diabetes mellitus. | 2001 Mar |
1 |
| 289 |
11356916 | A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism. | 2001 Jun |
1 |
| 290 |
11455676 | Comparison of the effects of three sulfonylureas on in vivo insulin action. | 2001 |
1 |
| 291 |
11473038 | Acute and short-term administration of a sulfonylurea (gliclazide) increases pulsatile insulin secretion in type 2 diabetes. | 2001 Aug |
1 |
| 292 |
11547215 | Therapeutic perspectives for type 2 diabetes mellitus: molecular and clinical insights. | 2001 Sep |
1 |
| 293 |
11585571 | Brain alpha-endosulfine is manifold decreased in brains from patients with Alzheimer's disease: a tentative marker and drug target? | 2001 Sep 14 |
1 |
| 294 |
11592575 | Gliclazide-induced hepatitis, hemiplegia and dysphasia in a suicide attempt. | 2001 Sep-Oct |
1 |
| 295 |
11596159 | Diabetes mellitus and cystic fibrosis: comparison of clinical parameters in patients treated with insulin versus oral glucose-lowering agents. | 2001 Nov |
1 |
| 296 |
11910976 | [Insulin and weight gain: myth or reality?]. | 2001 Nov |
1 |
| 297 |
23105297 | Insulin or sulfonylurea treatments of the diabetics differentially affect erythrocyte membrane and serum enzymes and extent of protein glycosylation. | 2001 Jan |
1 |
| 298 |
10872292 | [Therapy of type 2 diabetes. Critical evaluation of oral antidiabetic drugs]. | 2000 May 25 |
2 |
| 299 |
10878751 | Novel sulfonylurea and non-sulfonylurea drugs to promote the secretion of insulin. | 2000 Aug |
1 |
| 300 |
10928401 | Pharmacotherapy of type 2 diabetes mellitus. | 2000 Jul-Aug |
1 |